Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
3.990
-0.010 (-0.25%)
At close: Apr 23, 2026, 4:00 PM EDT
4.000
+0.010 (0.25%)
After-hours: Apr 23, 2026, 7:57 PM EDT
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.74 million as of April 23, 2026. Its market cap has increased by 24.77% in one year.
Market Cap
3.74M
Enterprise Value
3.83M
1-Year Change
24.77%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $3.74M, a decrease of -69.57%. That is a compound annual growth rate of -15.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 2.80M | 12.00% |
| Dec 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
| Jun 21, 2019 | 12.30M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 4.32M |
| AIM ImmunoTech | 4.29M |
| VivoSim Labs | 4.28M |
| Alzamend Neuro | 4.19M |
| Ensysce Biosciences | 4.02M |
| GRI Bio | 3.77M |
| Matinas BioPharma Holdings | 3.59M |
| Azitra | 3.47M |